Tomasz Kos

1.6k total citations
37 papers, 1.3k citations indexed

About

Tomasz Kos is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Tomasz Kos has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 17 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in Tomasz Kos's work include Neuroscience and Neuropharmacology Research (18 papers), Receptor Mechanisms and Signaling (11 papers) and Neurotransmitter Receptor Influence on Behavior (11 papers). Tomasz Kos is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Receptor Mechanisms and Signaling (11 papers) and Neurotransmitter Receptor Influence on Behavior (11 papers). Tomasz Kos collaborates with scholars based in Poland, United States and Germany. Tomasz Kos's co-authors include Piotr Popik, Agnieszka Nikiforuk, Agnieszka Potasiewicz, Małgorzata Hołuj, Wojciech Danysz, Anton Bespalov, Irina Belozertseva, Anna Wesołowska, Gabriel Nowak and Katarzyna Fijał and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Tomasz Kos

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomasz Kos Poland	23	724	585	428	320	153	37	1.3k
Huailing Zhong United States	16	750 1.0×	917 1.6×	469 1.1×	200 0.6×	142 0.9×	29	1.8k
Jesper T. Andreasen Denmark	23	550 0.8×	455 0.8×	182 0.4×	219 0.7×	187 1.2×	54	1.2k
Richard T. Layer United States	22	1.3k 1.7×	859 1.5×	471 1.1×	352 1.1×	233 1.5×	33	2.0k
Pierre Blier Canada	11	1.1k 1.5×	600 1.0×	415 1.0×	160 0.5×	197 1.3×	14	1.5k
Mercè Amargós‐Bosch Spain	9	818 1.1×	343 0.6×	282 0.7×	183 0.6×	226 1.5×	10	1.1k
Johann Meunier France	24	541 0.7×	866 1.5×	383 0.9×	318 1.0×	109 0.7×	39	1.9k
Jana Tchekalarova Bulgaria	24	681 0.9×	449 0.8×	214 0.5×	188 0.6×	182 1.2×	115	1.7k
Holger Rosenbrock Germany	23	512 0.7×	525 0.9×	264 0.6×	115 0.4×	206 1.3×	62	1.2k
Ouissame Mnie‐Filali France	18	747 1.0×	413 0.7×	241 0.6×	142 0.4×	209 1.4×	31	1.1k
Samantha L. McLean United Kingdom	15	1.0k 1.4×	804 1.4×	210 0.5×	241 0.8×	277 1.8×	29	1.7k

Countries citing papers authored by Tomasz Kos

Since Specialization

Citations

This map shows the geographic impact of Tomasz Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Kos more than expected).

Fields of papers citing papers by Tomasz Kos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Kos. The network helps show where Tomasz Kos may publish in the future.

Co-authorship network of co-authors of Tomasz Kos

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Kos. A scholar is included among the top collaborators of Tomasz Kos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Kos. Tomasz Kos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kos, Tomasz, Małgorzata Hołuj, Piotr Jakubowski, et al.. (2022). A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects. Frontiers in Pharmacology. 13. 999685–999685. 5 indexed citations

Zajdel, Paweł, Katarzyna Grychowska, Szczepan Mogilski, et al.. (2021). Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT₃ and 5-HT₆ Receptor Antagonist with Antipsychotic and Procognitive Properties. Journal of Medicinal Chemistry. 64(18). 13279–13298. 11 indexed citations

Kozela, Ewa, Martyna Krawczyk, Tomasz Kos, et al.. (2019). Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats. Molecular Neurobiology. 57(3). 1733–1747. 33 indexed citations

Soural, Miroslav, Vittorio Canale, Séverine Chaumont‐Dubel, et al.. (2017). Novel non-sulfonamide 5-HT 6 receptor partial inverse agonist in a group of imidazo[4,5- b ]pyridines with cognition enhancing properties. European Journal of Medicinal Chemistry. 144. 716–729. 35 indexed citations

Canale, Vittorio, Anna Partyka, Rafał Kurczab, et al.. (2017). Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. Bioorganic & Medicinal Chemistry. 25(10). 2789–2799. 20 indexed citations

Żurawek, Dariusz, et al.. (2017). Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia. Schizophrenia Research. 192. 423–430. 11 indexed citations

Zajdel, Paweł, Krzysztof Marciniec, Grzegorz Satała, et al.. (2016). N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties. ACS Medicinal Chemistry Letters. 7(6). 618–622. 39 indexed citations

Potasiewicz, Agnieszka, Małgorzata Hołuj, Tomasz Kos, et al.. (2016). 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats. Neuropharmacology. 113(Pt A). 188–197. 40 indexed citations

Skolnick, Phil, et al.. (2015). Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test. Acta Neuropsychiatrica. 27(4). 228–234. 13 indexed citations

10.

Nikiforuk, Agnieszka, Tomasz Kos, Agnieszka Potasiewicz, & Piotr Popik. (2015). Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. European Neuropsychopharmacology. 25(8). 1300–1313. 65 indexed citations

11.

Jedynak, Paulina, Tomasz Kos, Carmen Sandi, Leszek Kaczmarek, & Robert K. Filipkowski. (2014). Mice with ablated adult brain neurogenesis are not impaired in antidepressant response to chronic fluoxetine. Journal of Psychiatric Research. 56. 106–111. 22 indexed citations

12.

Nikiforuk, Agnieszka, et al.. (2013). Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats. PLoS ONE. 8(6). e66695–e66695. 83 indexed citations

13.

Nikiforuk, Agnieszka, Tomasz Kos, & Anna Wesołowska. (2011). The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. Psychopharmacology. 217(3). 411–418. 45 indexed citations

14.

Nikiforuk, Agnieszka, et al.. (2011). Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner. Neuropharmacology. 61(1-2). 262–267. 21 indexed citations

15.

Kos, Tomasz, et al.. (2010). The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology. 214(4). 911–921. 52 indexed citations

16.

Popik, Piotr, et al.. (2010). Memantine reduces consumption of highly palatable food in a rat model of binge eating. Amino Acids. 40(2). 477–485. 33 indexed citations

17.

Belozertseva, Irina, Tomasz Kos, Piotr Popik, Wojciech Danysz, & Anton Bespalov. (2006). Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. European Neuropsychopharmacology. 17(3). 172–179. 162 indexed citations

18.

Kos, Tomasz, Beata Legutko, Wojciech Danysz, Gary M. Samoriski, & Piotr Popik. (2006). Enhancement of Antidepressant-Like Effects but Not Brain-Derived Neurotrophic Factor mRNA Expression by the Novel N-Methyl-d-aspartate Receptor Antagonist Neramexane in Mice. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1128–1136. 25 indexed citations

19.

Kozela, Ewa, Tomasz Kos, Jacek Wójcikowski, et al.. (2005). 2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice. Psychopharmacology. 183(3). 275–284. 14 indexed citations

20.

Popik, Piotr, Martyna Krawczyk, Tomasz Kos, et al.. (2005). Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence. European Journal of Pharmacology. 515(1-3). 128–133. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact